Sumitomo Mitsui Trust Holdings, Inc. United Therapeutics Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $156 Billion
  • Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 100,248 shares of UTHR stock, worth $43.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
100,248
Previous 97,727 2.58%
Holding current value
$43.4 Million
Previous $30.1 Million 4.38%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$276.47 - $328.4 $696,980 - $827,896
2,521 Added 2.58%
100,248 $28.8 Million
Q1 2025

Apr 25, 2025
BUY
$304.42 - $380.78 $1.23 Million - $1.54 Million
4,054 Added 4.33%
97,727 $30.1 Million
Q4 2024

Jan 28, 2025
SELL
$348.66 - $410.0 $2 Million - $2.35 Million
-5,736 Reduced 5.77%
93,673 $33.1 Million
Q3 2024

Nov 05, 2024
SELL
$311.04 - $363.55 $132,192 - $154,508
-425 Reduced 0.43%
99,409 $35.6 Million
Q2 2024

Jul 19, 2024
SELL
$228.26 - $319.04 $275,738 - $385,400
-1,208 Reduced 1.2%
99,834 $31.8 Million
Q1 2024

Apr 19, 2024
BUY
$210.76 - $249.51 $71,236 - $84,334
338 Added 0.34%
101,042 $23.2 Million
Q4 2023

Jan 30, 2024
BUY
$214.88 - $256.94 $137,523 - $164,441
640 Added 0.64%
100,704 $22.1 Million
Q3 2023

Oct 30, 2023
BUY
$211.82 - $248.24 $118,619 - $139,014
560 Added 0.56%
100,064 $22.6 Million
Q2 2023

Jul 31, 2023
SELL
$205.19 - $232.99 $3.36 Million - $3.82 Million
-16,383 Reduced 14.14%
99,504 $22 Million
Q1 2023

Apr 27, 2023
BUY
$212.99 - $276.17 $24.3 Million - $31.5 Million
113,987 Added 5999.32%
115,887 $26 Million
Q4 2022

Jan 30, 2023
SELL
$205.95 - $280.43 $164,760 - $224,344
-800 Reduced 29.63%
1,900 $528,000
Q3 2022

Oct 21, 2022
BUY
$203.3 - $244.17 $101,650 - $122,085
500 Added 22.73%
2,700 $565,000
Q2 2022

Jul 26, 2022
BUY
$174.81 - $241.14 $87,405 - $120,570
500 Added 29.41%
2,200 $518,000
Q1 2022

Apr 27, 2022
SELL
$166.16 - $213.96 $33,232 - $42,792
-200 Reduced 10.53%
1,700 $305,000
Q4 2021

Feb 02, 2022
BUY
$184.32 - $216.08 $350,208 - $410,552
1,900 New
1,900 $411,000
Q3 2021

Oct 25, 2021
SELL
$179.86 - $214.88 $341,734 - $408,272
-1,900 Closed
0 $0
Q2 2021

Aug 02, 2021
SELL
$170.47 - $211.93 $238,658 - $296,702
-1,400 Reduced 42.42%
1,900 $341,000
Q1 2021

Apr 30, 2021
SELL
$153.94 - $174.85 $138,546 - $157,365
-900 Reduced 21.43%
3,300 $552,000
Q4 2020

Feb 05, 2021
SELL
$101.87 - $151.79 $947,696 - $1.41 Million
-9,303 Reduced 68.9%
4,200 $638,000
Q3 2020

Oct 30, 2020
BUY
$99.9 - $121.13 $1.35 Million - $1.64 Million
13,503 New
13,503 $1.36 Million
Q2 2020

Jul 27, 2020
SELL
$92.74 - $125.82 $1.25 Million - $1.69 Million
-13,434 Closed
0 $0
Q1 2020

Apr 27, 2020
BUY
$79.39 - $115.35 $1.07 Million - $1.55 Million
13,434 New
13,434 $1.27 Million
Q2 2019

Jul 29, 2019
SELL
$76.06 - $120.81 $13.1 Million - $20.8 Million
-172,077 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$107.15 - $126.84 $116,900 - $138,382
1,091 Added 0.64%
172,077 $20.2 Million
Q4 2018

Feb 06, 2019
BUY
$101.4 - $128.73 $3.71 Million - $4.7 Million
36,544 Added 27.18%
170,986 $18 Million
Q3 2018

Nov 07, 2018
BUY
$113.81 - $129.46 $104,591 - $118,973
919 Added 0.69%
134,442 $17.2 Million
Q2 2018

Aug 01, 2018
BUY
$101.14 - $118.31 $825,302 - $965,409
8,160 Added 6.51%
133,523 $15.1 Million
Q1 2018

May 01, 2018
BUY
$107.21 - $151.94 $100,026 - $141,760
933 Added 0.75%
125,363 $14.1 Million
Q4 2017

Feb 06, 2018
BUY
$118.58 - $151.28 $429,378 - $547,784
3,621 Added 3.0%
124,430 $18.4 Million
Q3 2017

Nov 07, 2017
SELL
$114.6 - $136.81 $252,922 - $301,939
-2,207 Reduced 1.79%
120,809 $14.2 Million
Q2 2017

Aug 07, 2017
BUY
N/A
123,016
123,016 $16 Million

Others Institutions Holding UTHR

# of Institutions
750
Shares Held
43.7M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $19.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email